ARMISTICE CAPITAL, LLC - 31 Dec 2025 SCHEDULE 13G Report for Biodexa Pharmaceuticals Plc American Depositary Shares, each representing four hundred ordinary shares (BDRX)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Biodexa Pharmaceuticals Plc American Depositary Shares, each representing four hundred ordinary shares
Symbol: BDRX
Shares outstanding: 2,837,858 shares
Disclosed Ownership: 283,502 shares
Ownership: 10%
Form type: SCHEDULE 13G
Filing time: 17 Feb 2026, 21:55:22 UTC
Date of event: 31 Dec 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	10%	283,502	0	283,502	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	10%	283,502	0	283,502	/s/ Steven Boyd	Steven Boyd